Home The Word Brain	My Amedeo FAQ Privacy About
	Explore this week’s CC Journal Club 90‑sec video • 4‑min audio • paper abstracts

HIV Infection

Free Subscription 21.04.2025 3 AIDS 2 AIDS Res Hum Retroviruses 1 Am J Med 3 Antivir Ther 1 BMC Pediatr 1 BMJ 4 Clin Infect Dis 2 HIV Med 5 J Acquir Immune Defic Syndr 1 J Clin Invest 1 J Immunol 2 J Infect Dis 2 J Med Virol 2 J Virol 3 Lancet 1 N Engl J Med 1 Nat Med 1 Nature 5 Pediatr Infect Dis J 1 Pediatrics 3 PLoS One 1 PLoS Pathog 1 Virology

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

AIDS

1. OH TK, Song KH, Heo E, Song IA, et al
   Association between HIV and cancer risk: a nationwide, population-based cohort study.
   AIDS. 2025 Apr 15. doi: 10.1097/QAD.0000000000004210.
   PubMed         Abstract available
   
   
2. NAMPOTA-NKOMBA N, Mohanty K, Adebiyi R, Ekeh C, et al
   Penile human papillomavirus prevalence in circumcised sexual minority men living with and without HIV.
   AIDS. 2025 Apr 15. doi: 10.1097/QAD.0000000000004209.
   PubMed         Abstract available
   
   
3. GLENN JS, Bennett A, Mackie N, Lyall H, et al
   The cumulative prevalence of HIV-1 drug resistance in perinatal HIV.
   AIDS. 2025 Apr 4. doi: 10.1097/QAD.0000000000004202.
   PubMed         Abstract available
   
   

   
   AIDS Res Hum Retroviruses

4. CHEN M, Chen H, Dai J, Dong L, et al
   Identification of a Novel Second-Generation HIV-1 Circulating Recombinant Form (CRF174_0708) Arising from CRF07_BC and CRF08_BC in Yunnan, China.
   AIDS Res Hum Retroviruses. 2025 Apr 14. doi: 10.1089/aid.2025.0022.
   PubMed         Abstract available
   
   
5. YU M, Wang X, Jia L, Han J, et al
   Sequence Notes: Identification of Two New CRF01_AE/CRF07_BC Recombinants in Men Who Have Sex with Men Populations in Beijing, China.
   AIDS Res Hum Retroviruses. 2025 Apr 14. doi: 10.1089/aid.2024.0098.
   PubMed         Abstract available
   
   

   
   Am J Med

6. JOSEPH S, Borja Y, Gavathas P, Ammar H, et al
   It's not always Molluscum: A case of disseminated Cryptococcosis.
   Am J Med. 2025 Apr 12:S0002-9343(25)00233-5. doi: 10.1016/j.amjmed.2025.
   PubMed        
   
   

   
   Antivir Ther

7. ELEJE GU, Usman HA, Onubogu CU, Fiebai PO, et al
   Seroprevalence, seroconversion, and mother-to-child transmission of dual and triplex infections of HIV, HBV, and HCV among Nigerian obstetric population: A national multicentre prospective cohort study.
   Antivir Ther. 2025;30:13596535251333259.
   PubMed         Abstract available
   
   
8. PALLANZA M, Thoueille P, Briki M, Alves Saldanha S, et al
   Sustained viral suppression with once daily dolutegravir-containing regimen in presence of the strong inducer carbamazepine.
   Antivir Ther. 2025;30:13596535251335080.
   PubMed         Abstract available
   
   
9. LABATE L, Rossetti B, Russo C, Cassol C, et al
   Durability of multi-drug antiretroviral therapy (mega-ART) in treatment-experienced people with HIV in the ARCA database.
   Antivir Ther. 2025;30:13596535251317054.
   PubMed         Abstract available
   
   

   
   BMC Pediatr

10. M Y, Vamja R, Parmar PA, Makwana N, et al
    Diagnostic utility of haematological parameters for tuberculosis in children living with HIV (0-14 years): a retrospective cohort study.
    BMC Pediatr. 2025;25:301.
    PubMed         Abstract available
    
    

    
    BMJ

11. DYER O
    Trump's HIV cuts bite hard in Africa and at home.
    BMJ. 2025;389:r771.
    PubMed        
    
    

    
    Clin Infect Dis

12. KIM S, Pelissari DM, Harada LO, Sanchez M, et al
    Long-term mortality trends among individuals with tuberculosis: a retrospective cohort study of individuals diagnosed with tuberculosis in Brazil.
    Clin Infect Dis. 2025 Apr 18:ciaf206. doi: 10.1093.
    PubMed         Abstract available
    
    
13. BREGER TL, Westreich DJ, Edmonds A, Edwards JK, et al
    Incidence of statin initiation among people with and without HIV in the US: a prospective observational study.
    Clin Infect Dis. 2025 Apr 17:ciaf207. doi: 10.1093.
    PubMed         Abstract available
    
    
14. MONTEPIEDRA G, Aaron L, Theron G, McCarthy K, et al
    Hepatotoxicity Among People Living with HIV and Receiving Isoniazid Preventive Therapy in Pregnancy and Postpartum: The Role of Antiretroviral Regimen and Pharmacogenetics.
    Clin Infect Dis. 2025 Apr 16:ciaf198. doi: 10.1093.
    PubMed         Abstract available
    
    
15. KULIK GL, Mollner DC, Barbera L, Walker J, et al
    Application of Pragmatic Criteria to Assessments of Frailty and Physical Function among People with HIV.
    Clin Infect Dis. 2025 Apr 15:ciaf193. doi: 10.1093.
    PubMed         Abstract available
    
    

    
    HIV Med

16. 
    Correction to "Perception of medical care among women living with HIV aged 40 years or older-a European-wide survey".
    HIV Med. 2025 Apr 14. doi: 10.1111/hiv.70032.
    PubMed        
    
    
17. ADMASSU Z, Logie CH, Vahedi L, Underhill A, et al
    Longitudinal associations between social determinants of health and well-being among women living with HIV in Canada: A latent class analysis.
    HIV Med. 2025 Apr 14. doi: 10.1111/hiv.70031.
    PubMed         Abstract available
    
    

    
    J Acquir Immune Defic Syndr

18. CRANE HM, Ruderman SA, Nance RM, Drumright LN, et al
    Approaches to optimally target frailty screening among people with HIV in clinical care: findings from the Centers for AIDS Research Network of Integrated Clinical Systems (CNICS).
    J Acquir Immune Defic Syndr. 2025 Apr 17. doi: 10.1097/QAI.0000000000003688.
    PubMed         Abstract available
    
    
19. NAMPOTA-NKOMBA N, Buchwald A, Nyirenda OM, Mkandawire FA, et al
    Association between Maternal HIV and Adverse Birth Outcomes in the Era of Universal Antiretroviral Therapy in Malawi.
    J Acquir Immune Defic Syndr. 2025 Apr 17. doi: 10.1097/QAI.0000000000003685.
    PubMed         Abstract available
    
    
20. NDONGO FA, Tejiokem MC, Penda CI, Ndiang ST, et al
    IMMUNOLOGICAL AND VIROLOGIC OUTCOMES WITHIN TEN YEARS OF COMBINED ANTIRETROVIRAL THERAPY INITIATED BEFORE ONE YEAR OF AGE IN CAMEROONIAN CHILDREN WITH PERINATAL HIV.
    J Acquir Immune Defic Syndr. 2025 Apr 17. doi: 10.1097/QAI.0000000000003687.
    PubMed         Abstract available
    
    
21. MAROTTA PL, Humphries D, Escudero D, Katz DA, et al
    Strengthening the US Health Workforce to End the HIV Epidemic: Lessons Learned From 11 EHE Jurisdictions: Erratum.
    J Acquir Immune Defic Syndr. 2025 Apr 18. doi: 10.1097/QAI.0000000000003683.
    PubMed        
    
    
22. HUMPHRIES DL, Audet CM, Balasubramanian BA, Benbow N, et al
    Building the Road to End the HIV Epidemic Through Coordinating and Capacity-Building Hubs to Enhance the Science of HIV Implementation REsearch (CHESHIRE): Reflections and Directions: Erratum.
    J Acquir Immune Defic Syndr. 2025 Apr 18. doi: 10.1097/QAI.0000000000003684.
    PubMed        
    
    

    
    J Clin Invest

23. PAL PB, Iyer SS
    Transient pain and long-term gain: adjuvant dose directs immune memory.
    J Clin Invest. 2025;135:e190524.
    PubMed         Abstract available
    
    

    
    J Immunol

24. DING C, Chen Q, Shi Y, Liu J, et al
    Impact of CD4+ T cell and TCR repertoires on SARS-CoV-2-Specific antibody responses in PLWH following COVID-19 vaccination.
    J Immunol. 2025 Apr 15:vkae040. doi: 10.1093.
    PubMed         Abstract available
    
    

    
    J Infect Dis

25. RONN MM, Chesson HW, Grad YH, Reitsma M, et al
    The influence of epidemiological context on the success of partner notification programs: analysis of gonorrhea transmission dynamics.
    J Infect Dis. 2025 Apr 18:jiaf206. doi: 10.1093.
    PubMed         Abstract available
    
    
26. WANG Y, Brichacek B, Dubrovsky L, Pushkarsky T, et al
    Increased atherosclerosis in HIV-infected humanized mice is caused by a single viral protein, Nef.
    J Infect Dis. 2025 Apr 16:jiaf192. doi: 10.1093.
    PubMed         Abstract available
    
    

    
    J Med Virol

27. WEI Q, Chen L, Yin Y, Pai M, et al
    Analysis of Blood Microbiome From People Living With HIV and Donors by 16S rRNA Metagenomic Sequencing.
    J Med Virol. 2025;97:e70341.
    PubMed         Abstract available
    
    
28. DEMIRDJIAN S, Naik V, Margot N, Falkard B, et al
    Phenotypic Characterization of Replication-Impaired Lenacapavir-Resistant HIV Clinical Isolates.
    J Med Virol. 2025;97:e70340.
    PubMed         Abstract available
    
    

    
    J Virol

29. MOORAD R, Peng A, Landis J, Pluta LJ, et al
    Genome evolution of Kaposi sarcoma-associated herpesvirus (KSHV).
    J Virol. 2025 Apr 16:e0195024. doi: 10.1128/jvi.01950.
    PubMed         Abstract available
    
    
30. GROVES NS, Clark AR, Aguilar RS, Hikichi Y, et al
    A monomeric envelope glycoprotein cytoplasmic tail is sufficient for HIV-1 Gag lattice trapping and incorporation.
    J Virol. 2025 Apr 15:e0210524. doi: 10.1128/jvi.02105.
    PubMed         Abstract available
    
    

    
    Lancet

31. UNEMO M, Wi T
    Gepotidacin shows promise for the treatment of uncomplicated gonorrhoea.
    Lancet. 2025 Apr 11:S0140-6736(25)00680-4. doi: 10.1016/S0140-6736(25)00680.
    PubMed        
    
    
32. ROSS JDC, Wilson J, Workowski KA, Taylor SN, et al
    Oral gepotidacin for the treatment of uncomplicated urogenital gonorrhoea (EAGLE-1): a phase 3 randomised, open-label, non-inferiority, multicentre study.
    Lancet. 2025 Apr 11:S0140-6736(25)00628-2. doi: 10.1016/S0140-6736(25)00628.
    PubMed         Abstract available
    
    
33. NDEMBI N, Karuna S, Cowden J, Cagigi A, et al
    Accelerating vaccine development in Africa: lessons from HIV research.
    Lancet. 2025 Apr 10:S0140-6736(25)00564-1. doi: 10.1016/S0140-6736(25)00564.
    PubMed        
    
    

    
    N Engl J Med

34. RASKO JEJ, Samelson-Jones BJ, George LA, Giermasz A, et al
    Fidanacogene Elaparvovec for Hemophilia B - A Multiyear Follow-up Study.
    N Engl J Med. 2025;392:1508-1517.
    PubMed         Abstract available
    
    

    
    Nat Med

35. 
    Extreme inequities in access to HIV treatment in Malawi.
    Nat Med. 2025 Apr 15. doi: 10.1038/s41591-025-03676.
    PubMed        
    
    

    
    Nature

36. MALLAPATY S
    25 million deaths: what could happen if the US ends global health funding.
    Nature. 2025 Apr 17. doi: 10.1038/d41586-025-01191.
    PubMed        
    
    

    
    Pediatr Infect Dis J

37. WACHARACHAISURAPOL N, Rungsapphaiboon A, Anugulruengkitt S, Sirikutt P, et al
    Pharmacokinetics of Generic Pediatric Abacavir/Lamivudine Dispersible Tablets in Thai Young Children Living With HIV Weighing Below Twenty Kilograms.
    Pediatr Infect Dis J. 2025;44:428-430.
    PubMed         Abstract available
    
    
38. PATTEN G, Malateste K, Bolton Moore C, Sipambo N, et al
    Global Trends in CD4 Measurement and Immunosuppression at ART Initiation Among Children With HIV.
    Pediatr Infect Dis J. 2025 Apr 4. doi: 10.1097/INF.0000000000004819.
    PubMed         Abstract available
    
    
39. PRABHUDAS-STRYCKER K, Waugh M, Bates B, Weaver B, et al
    Postpandemic Trends and Missed Opportunities in Prevention and Diagnosis of Pediatric HIV.
    Pediatr Infect Dis J. 2025 Apr 15. doi: 10.1097/INF.0000000000004822.
    PubMed         Abstract available
    
    
40. ANTWI S, Enimil A, Yang H, Martyn-Dickens C, et al
    Pharmacokinetics of Tenofovir Diphosphate, Lamivudine Triphosphate and Emtricitabine Triphosphate in Adolescents With HIV Infection With and Without Tuberculosis Coinfection.
    Pediatr Infect Dis J. 2025 Apr 10. doi: 10.1097/INF.0000000000004831.
    PubMed         Abstract available
    
    
41. LOMBAARD J, Moolasart V, Lutaakome J, Van Solingen-Ristea R, et al
    Pharmacokinetics, Safety and Antiviral Activity of Rilpivirine in Antiretroviral-naive Children With HIV >/=6 to <12 Years Old: Week 48 and Final Analysis of Cohort 2 From the Open-label, Phase 2 PAINT Study.
    Pediatr Infect Dis J. 2025 Apr 18. doi: 10.1097/INF.0000000000004828.
    PubMed         Abstract available
    
    

    
    Pediatrics

42. POOSER M, Yuan Y, Karki S, O'Callaghan K, et al
    The Incidence of Neonatal Herpes Simplex Virus Infections in the United States: 2019.
    Pediatrics. 2025 Apr 14:e2024067348. doi: 10.1542/peds.2024-067348.
    PubMed         Abstract available
    
    

    
    PLoS One

43. ALLY ZM, Moshi L, Musoke R, Mbwana MS, et al
    Trend of genital ulcers and discharge and associated factors among survey respondents in Tanzania, 2004-2022: Analysis of demographic health surveys.
    PLoS One. 2025;20:e0319467.
    PubMed         Abstract available
    
    
44. KOAY WLA, Ganesan K, Unternaher J, Morrison S, et al
    Implementation of adolescent HIV screening in two urban pediatric emergency departments in the United States.
    PLoS One. 2025;20:e0321473.
    PubMed         Abstract available
    
    
45. KITAW TA, Azmeraw M, Abate BB, Tilahun BD, et al
    The burden of HIV/AIDS in Ethiopia: Unveiling 30 years of trends in incidence, mortality, and disability-insights from the Global Burden of Disease study (1990-2021).
    PLoS One. 2025;20:e0321024.
    PubMed         Abstract available
    
    

    
    PLoS Pathog

46. BUCHANAN LB, Shao Z, Galiwango RM, Constable S, et al
    HIV-associated penile anaerobes disrupt epithelial barrier integrity.
    PLoS Pathog. 2025;21:e1013094.
    PubMed         Abstract available
    
    

    
    Virology

47. BELL JT, Zhang X
    The hepatitis B virus surface antigen: An evolved perfection and its unresolved mysteries.
    Virology. 2025;608:110527.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO HIV Infection is free of charge.